We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
GNC Holdings (GNC) Beats on Q1 Earnings, Plans Store Shutdown
Read MoreHide Full Article
GNC Holdings, Inc. (GNC - Free Report) reported first-quarter 2018 adjusted earnings per share (EPS)of 24 cents, reflecting a 36.8% year-over-year decline. Adjusted EPS surpassed the Zacks Consensus Estimate of 20 cents by 20%.
Revenues
Revenues (which now exclude Lucky Vitamin in all periods) in the reported quarter dropped 7.2% year over year to $607.5 million.The drop was primarily because of the sale of Lucky Vitamin in September 2017 and the termination of the Gold Card program.
Same-store sales increased 0.5% in domestic company-owned stores (including GNC.com sales) in the quarter under review. Notably, this is the third straight quarter of growth. In domestic franchise locations, same-store sales dropped 1.9%.
GNC Holdings, Inc. Price, Consensus and EPS Surprise
GNC Holdings reports operations under three segments: U.S. & Canada (including company-owned stores in the United States, Puerto Rico and Canada, franchise stores in the United States and e-commerce); International (including franchise locations in approximately 50 countries, The Health Store and China operations); and Manufacturing/Wholesale (comprising manufactured products sold to other segments, third-party contract manufacturing and sales to wholesale partners).
During the reported quarter, GNC Holdings’ revenues from the U.S. & Canada segment decreased 4.5% to $512.4 million. In domestic franchise locations, revenues declined $7.8 million due to a decrease in retail same store sales along with a reduction in the number of franchise stores.
Revenues at the International segment increased 0.8% to $40.1 million driven by higher cross-border e-commerce sales in China.
Revenues at the Manufacturing/Wholesale segment (excluding intersegment revenues) declined 1.4% to $55.1 million. Within this segment, third-party contract manufacturing sales fell by $0.9 million. However, Intersegment sales increased $3.4 million on the company's increased focus on proprietary products.
Margin
Gross profit declined 5.9% in the reported quarter to $206.9 million. However, gross margin expanded 48 basis points (bps) to 34.1% on rising penetration of the company’s private label brands.
Selling, general and administrative expenses contracted 3.2% to $160.7 million. Accordingly, adjusted operating margin dropped 62 bps to 7.6%.
Financial Position
GNC Holdings exited first-quarter 2018 with cash and cash equivalents of $53.9 million, up from $64 million at the end of 2017. Long-term debt was $1.06 billion in quarter under review, compared with $1.29 billion at 2017-end. Net cash flow from operating activities totaled $25.07 million, compared with $46.10 million a year ago.
Further, the company generated free cash flow of $37.4 million as compared with $33.4 million in the year-ago quarter.
One New GNC Plan Update
Earlier, management had announced plans to revamp its existing business model, dubbed as the ‘One New GNC'. Till now, more than 13 million consumers have joined the company's loyalty programs, including approximately 935,000 customers enrolled under the PRO Access membership.
Store Count Update
As of Mar 31, 2018, GNC Holdings had 3,385 corporate stores in the United States and Canada, 1,083 domestic franchise locations, 2,428 Rite Aid franchise store-within-a-store locations and 2,009 international locations. The company currently has 8,905 store locations globally. The company intends to shutter approximately 200 stores in 2018 as part of the ongoing optimization of the company's store portfolio. The company has also announced plans to open a limited number of new stores in 2018.
Our Take
GNC Holdings exited the first quarter of 2018 on a mixed note. The year-over-year fall in adjusted earnings and revenues is dampening.
The company has been firing on all cylinders to strengthen its international presence. In this regard, GNC Holdings recently announced that its proposal to enter into a strategic partnership and China joint venture agreement with Harbin Pharmaceutical Group Holding Co., Ltd ("Hayao") has received Hayao shareholders’ vote. Further, the company has recently entered into a master franchise agreement with Rapid Nutrition to foray in Australia. At the same time, GNC Holdings has also announced plans to expand presence in India where it operates in collaboration with the master franchise partner — Guardian Healthcare Services Pvt. Ltd. Thus, all these developments help in boosting investors faith on the stock.
Zacks Rank & Key Picks
GNC Holdings has a Zacks Rank #3 (Hold).
A few better-ranked stocks in the broader medical space, which reported solid earnings this season, are Laboratory Corporation of America Holdings (LH - Free Report) , Chemed Corporation (CHE - Free Report) and Intuitive Surgical, Inc. (ISRG - Free Report) . While Intuitive Surgical sports a Zacks Rank #1 (Strong Buy), LabCorp and Chemed carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Intuitive Surgical reported first-quarter 2018 EPS of $2.44 per share, which beat the Zacks Consensus Estimate by 22.6%. Revenues totaled $848 million, also surpassing the Zacks Consensus Estimate by 10.6%.
LabCorp reported first-quarter 2018 EPS of $2.78, beating the Zacks Consensus Estimate by 5.3%. Revenues came in at $2.85 billion, steering past the Zacks Consensus Estimate of $2.78 billion.
Chemed posted first-quarter 2018 EPS of $2.72, beating the Zacks Consensus Estimate of $2.37. Revenues came in at $439.2 million, surpassing the Zacks Consensus Estimate of $420 million.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
GNC Holdings (GNC) Beats on Q1 Earnings, Plans Store Shutdown
GNC Holdings, Inc. (GNC - Free Report) reported first-quarter 2018 adjusted earnings per share (EPS)of 24 cents, reflecting a 36.8% year-over-year decline. Adjusted EPS surpassed the Zacks Consensus Estimate of 20 cents by 20%.
Revenues
Revenues (which now exclude Lucky Vitamin in all periods) in the reported quarter dropped 7.2% year over year to $607.5 million.The drop was primarily because of the sale of Lucky Vitamin in September 2017 and the termination of the Gold Card program.
Same-store sales increased 0.5% in domestic company-owned stores (including GNC.com sales) in the quarter under review. Notably, this is the third straight quarter of growth. In domestic franchise locations, same-store sales dropped 1.9%.
GNC Holdings, Inc. Price, Consensus and EPS Surprise
GNC Holdings, Inc. Price, Consensus and EPS Surprise | GNC Holdings, Inc. Quote
Segments in Details
GNC Holdings reports operations under three segments: U.S. & Canada (including company-owned stores in the United States, Puerto Rico and Canada, franchise stores in the United States and e-commerce); International (including franchise locations in approximately 50 countries, The Health Store and China operations); and Manufacturing/Wholesale (comprising manufactured products sold to other segments, third-party contract manufacturing and sales to wholesale partners).
During the reported quarter, GNC Holdings’ revenues from the U.S. & Canada segment decreased 4.5% to $512.4 million. In domestic franchise locations, revenues declined $7.8 million due to a decrease in retail same store sales along with a reduction in the number of franchise stores.
Revenues at the International segment increased 0.8% to $40.1 million driven by higher cross-border e-commerce sales in China.
Revenues at the Manufacturing/Wholesale segment (excluding intersegment revenues) declined 1.4% to $55.1 million. Within this segment, third-party contract manufacturing sales fell by $0.9 million. However, Intersegment sales increased $3.4 million on the company's increased focus on proprietary products.
Margin
Gross profit declined 5.9% in the reported quarter to $206.9 million. However, gross margin expanded 48 basis points (bps) to 34.1% on rising penetration of the company’s private label brands.
Selling, general and administrative expenses contracted 3.2% to $160.7 million. Accordingly, adjusted operating margin dropped 62 bps to 7.6%.
Financial Position
GNC Holdings exited first-quarter 2018 with cash and cash equivalents of $53.9 million, up from $64 million at the end of 2017. Long-term debt was $1.06 billion in quarter under review, compared with $1.29 billion at 2017-end. Net cash flow from operating activities totaled $25.07 million, compared with $46.10 million a year ago.
Further, the company generated free cash flow of $37.4 million as compared with $33.4 million in the year-ago quarter.
One New GNC Plan Update
Earlier, management had announced plans to revamp its existing business model, dubbed as the ‘One New GNC'. Till now, more than 13 million consumers have joined the company's loyalty programs, including approximately 935,000 customers enrolled under the PRO Access membership.
Store Count Update
As of Mar 31, 2018, GNC Holdings had 3,385 corporate stores in the United States and Canada, 1,083 domestic franchise locations, 2,428 Rite Aid franchise store-within-a-store locations and 2,009 international locations. The company currently has 8,905 store locations globally. The company intends to shutter approximately 200 stores in 2018 as part of the ongoing optimization of the company's store portfolio. The company has also announced plans to open a limited number of new stores in 2018.
Our Take
GNC Holdings exited the first quarter of 2018 on a mixed note. The year-over-year fall in adjusted earnings and revenues is dampening.
The company has been firing on all cylinders to strengthen its international presence. In this regard, GNC Holdings recently announced that its proposal to enter into a strategic partnership and China joint venture agreement with Harbin Pharmaceutical Group Holding Co., Ltd ("Hayao") has received Hayao shareholders’ vote. Further, the company has recently entered into a master franchise agreement with Rapid Nutrition to foray in Australia. At the same time, GNC Holdings has also announced plans to expand presence in India where it operates in collaboration with the master franchise partner — Guardian Healthcare Services Pvt. Ltd. Thus, all these developments help in boosting investors faith on the stock.
Zacks Rank & Key Picks
GNC Holdings has a Zacks Rank #3 (Hold).
A few better-ranked stocks in the broader medical space, which reported solid earnings this season, are Laboratory Corporation of America Holdings (LH - Free Report) , Chemed Corporation (CHE - Free Report) and Intuitive Surgical, Inc. (ISRG - Free Report) . While Intuitive Surgical sports a Zacks Rank #1 (Strong Buy), LabCorp and Chemed carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Intuitive Surgical reported first-quarter 2018 EPS of $2.44 per share, which beat the Zacks Consensus Estimate by 22.6%. Revenues totaled $848 million, also surpassing the Zacks Consensus Estimate by 10.6%.
LabCorp reported first-quarter 2018 EPS of $2.78, beating the Zacks Consensus Estimate by 5.3%. Revenues came in at $2.85 billion, steering past the Zacks Consensus Estimate of $2.78 billion.
Chemed posted first-quarter 2018 EPS of $2.72, beating the Zacks Consensus Estimate of $2.37. Revenues came in at $439.2 million, surpassing the Zacks Consensus Estimate of $420 million.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>